We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+30.27%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$116B
AUM Growth
+$12.9B
Cap. Flow
-$8.24B
Cap. Flow %
-7.11%
Top 10 Hldgs %
14.35%
Holding
3,987
New
584
Increased
1,418
Reduced
1,366
Closed
596

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$806M
2
ABBV icon
AbbVie
ABBV
+$481M
3
TMUS icon
T-Mobile US
TMUS
+$464M
4
KR icon
Kroger
KR
+$430M
5
BIDU icon
Baidu
BIDU
+$423M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.35B
2
AGN
Allergan plc
AGN
+$1.26B
3
S
Sprint Corporation
S
+$675M
4
AMGN icon
Amgen
AMGN
+$488M
5
HUM icon
Humana
HUM
+$450M

Sector Composition

Rank Sector Weight
1 Healthcare 23.45%
2 Technology 16.09%
3 Consumer Staples 10.57%
4 Consumer Discretionary 9.95%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELTK icon
3326
Eltek
ELTK
$57.1M
$59K ﹤0.01%
+14,880
New +$59.1K
HYPD
3327
Hyperion DeFi Inc
HYPD
$42.9M
$59K ﹤0.01%
+260
New +$64.4K
KOSS icon
3328
Koss Corp
KOSS
$34.7M
$59K ﹤0.01%
43,401
+13,905
+47% +$17K
ADIL
3329
Adial Pharmaceuticals
ADIL
$9.61M
$58K ﹤0.01%
+67
New +$60.5K
JXG
3330
JX Luxventure
JXG
$85.6M
$58K ﹤0.01%
40
+21
+111% +$23.4K
STRR
3331
DELISTED
Star Equity Holdings
STRR
$57K ﹤0.01%
4,058
-14,004
-78% -$198K
XELA
3332
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$57K ﹤0.01%
+9
New +$36.3K
XELB icon
3333
Xcel Brands
XELB
$6.42M
$55K ﹤0.01%
6,120
+2,815
+85% +$22.4K
CYTO
3334
DELISTED
Altamira Therapeutics Ltd
CYTO
$54K ﹤0.01%
+143
New +$53.7K
NEWA
3335
DELISTED
Newater Technology, Inc. Ordinary Shares
NEWA
$54K ﹤0.01%
14,800
+500
+3% +$1.35K
JAGX icon
3336
Jaguar Health
JAGX
$3.85M
0
STAF
3337
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$53K ﹤0.01%
111
+34
+44% +$13.7K
BDR
3338
DELISTED
Blonder Tongue Laboratories Inc
BDR
$53K ﹤0.01%
74,157
+4,400
+6% +$2.61K
PSV
3339
DELISTED
Hermitage Offshore Services Ltd.
PSV
$53K ﹤0.01%
+102,680
New +$65K
AMBO
3340
Ambow Education Holding
AMBO
$6.06M
$52K ﹤0.01%
2,934
+870
+42% +$17.6K
EDN
3341
Edenor
EDN
$1.04B
$52K ﹤0.01%
+13,100
New +$46.1K
ATHX
3342
DELISTED
Athersys, Inc. Common Stock
ATHX
$52K ﹤0.01%
752
-37,289
-98% -$2.59M
PXS icon
3343
Pyxis Tankers
PXS
$52.5M
$51K ﹤0.01%
+16,810
New +$61.5K
RETO icon
3344
ReTo Eco-Solutions
RETO
$10.2M
0
UUU icon
3345
Universal Safety Products Inc
UUU
$10.3M
$50K ﹤0.01%
62,823
+1,800
+3% +$1.12K
SGRP
3346
DELISTED
SPAR Group
SGRP
$49K ﹤0.01%
65,200
-25,800
-28% -$19.6K
DXYN
3347
DELISTED
Dixie Group Inc
DXYN
$48K ﹤0.01%
+52,200
New +$39.8K
GRIN
3348
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
$47K ﹤0.01%
17,200
+1,880
+12% +$4.75K
WIMI
3349
WiMi Hologram Cloud
WIMI
$24.5M
$44K ﹤0.01%
+1,280
New +$55.9K
PLG
3350
Platinum Group Metals
PLG
$189M
$42K ﹤0.01%
+28,500
New +$42.7K

Similar funds

Jim Simons's Q2 2020 Portfolio in Review

As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Jim Simons opened a new position in Uber worth $187M.

  • Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
  • Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
  • Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
  • Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
  • Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
  • Jim Simons opened 584 new positions and closed 596 in Q2 2020.
  • Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.

Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.